GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » Shares Buyback Ratio %

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Shares Buyback Ratio % : 0.00 (As of Jun. 08, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Henan Taloph Pharmaceutical Stock Co Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Henan Taloph Pharmaceutical Stock Co's current shares buyback ratio was 0.00%.

Henan Taloph Pharmaceutical Stock Co Shares Buyback Ratio % Historical Data

The historical data trend for Henan Taloph Pharmaceutical Stock Co's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Taloph Pharmaceutical Stock Co Shares Buyback Ratio % Chart

Henan Taloph Pharmaceutical Stock Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Henan Taloph Pharmaceutical Stock Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Henan Taloph Pharmaceutical Stock Co Shares Buyback Ratio % Calculation

Henan Taloph Pharmaceutical Stock Co's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(573.886 - 573.886) / 573.886
=0.00%

Henan Taloph Pharmaceutical Stock Co's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Mar. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(573.886 - 573.886) / 573.886
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Taloph Pharmaceutical Stock Co Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Henan Taloph Pharmaceutical Stock Co's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Taloph Pharmaceutical Stock Co Ltd (SHSE:600222) » Definitions » Shares Buyback Ratio %
Comparable Companies
SZSE:300436 SZSE:301331 SHSE:603538 SZSE:300254 SZSE:002107 SHSE:688117 SZSE:000153 SHSE:688373 SHSE:600594 SHSE:600513 XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
No. 8, Jinsuo Road, High-tech Industrial Development Zone, Henan Province, Zhengzhou, CHN, 450001
Website
http://www.taloph.com
Henan Taloph Pharmaceutical Stock Co Ltd is a Chinese company engaged in the manufacture of Western and Chinese medicine products, including oral liquids, tablets, capsules, and bulk drugs. Geographically, the business activities are functioned through China region.
Executives
Zhao Qing Xin Director

Henan Taloph Pharmaceutical Stock Co (SHSE:600222) Headlines

No Headlines